Sanofi-Aventis gets FDA OK for SarclisaSanofi-Aventis' Sarclisa works by helping certain cells in the immune system attack multiple myeloma cancer cells. Briefs from pharmacy groups ask Supreme Court to uphold Arkansas PBM lawNACDS has filed a brief supporting an Arkansas law at question in an upcoming Supreme Court case, and several pharmacy groups including NCPA, APA, APhA and NASPA have filed a separate brief also in support of the law. AAM aims to ensure access to generics, biosimilars during COVID-19 outbreak In the wake of the coronavirus spreading, the Association for Accessible Medicines said it will work to help ensure that patients in the United States get access to generic and biosimilar medicines. ANI gets FDA nod for memantine hydrochloride Memantine hydrochloride ER capsules have a market value of approximately $127 million, according to IQVIA. FDA approves Cerovene’s generic Daraprim The FDA has approved the first generic of Daraprim (pyrimethamine) tablets when used with a group of medicines to treat bacterial infections. Amplicare taps J. Bennet Waters as CEO; names Matthew Johnson president Matthew Johnson, Amplicare's co-founder and CEO, will assume the new role of president; J. Bennet Waters will serve as CEO. Biohaven gets FDA nod for Nurtec ODT Biohaven's Nurtec ODT is a single quick-dissolving oral tablet for adult patients with acute migraine. Mylan, Pfizer complete Viatris board of directors Mylan and Pfizer’s soon to be combined company Viatris has selected the remaining members to its 13-member board of directors. NACDS to serve as founding member of CDC’s National Hypertension Control Roundtable By 2025, the National Hypertension Control Roundtable seeks to improve national hypertension control rates from 50% to 80%. Dr. Reddy’s launches generic Vimovo Vimovo has a market value of approximately $414 million for the 12 months ended December 2019, according to IQVIA. First Previous 406 407 408 409 410 Next Last